A new class of quinolone antibiotic (e.g., moxifloxacin) is useful for treating otic, opthalmic or nasal infections attributed to a microbacterium species selected from microbacterium otitidis or microbacterium alconaeUS6740664 Jun 22, 2001 May 25, 2004 Alcon, Inc. Methods for treating otic and ...
Group A (n = 27) received the FQL antibiotic Moxifloxacin (Vigamox®, Alcon Laboratories, Fort Worth, TX, USA; preservative-free), Group B (n = 29) received another FQL antibiotic Ciprofloxacin (Ciplox®, Cipla Ltd., Ahmedabad, India; with preservative) and Group C (n = 26) received...
Moxifloxacin HClThe presence of antibiotics in water systems had raised a concern about their potential harm to the aquatic environment and human health as well as the possible development of antibiotic resistance. Herein, this study investigates the power of adsorption using graphene-polypyrrole (GRP-...
In Vitro Synergism of Beta-Lactams with Ciprofloxacin and Moxifloxacin against Genetically Distinct Multidrug-Resistant Isolates of Pseudomonas Aeruginosa. Int. J. Antimicrob. Agents 2008, 32, 33–39. [CrossRef] [PubMed] 16. Naghmouchi, K.; Le Lay, C.; Baah, J.; Drider, D. Antibiotic ...